Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AIDS Patients Care and STDs

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/apc.2016.0010PMID 27158847PMCID PMC4870651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level.

  2015cited by this paper
• Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status

  2015cited by this paper
• Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals

  2015cited by this paper
• Cellular mechanisms by which alcohol promotes HIV protease inhibitor‐induced liver lipotoxicity

  2015cited by this paper
• Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

  2015cited by this paper
• Trends in the management and burden of alcoholic liver disease

  2015cited by this paper
• Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.

  2014influential reference
• Interactions Between Alcohol and the Antiretroviral Medications Ritonavir or Efavirenz

  2013cited by this paper
• Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study

  2013cited by this paper
• HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease

  2013cited by this paper
• HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes

  2013cited by this paper
• Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

  2012cited by this paper
• Human immunodeficiency virus protease inhibitors modulate Ca2+ homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes

  2012cited by this paper
• Alcohol Consumption and CD4 T-Cell Count Response Among Persons Initiating Antiretroviral Therapy

  2012cited by this paper
• Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.

  2011cited by this paper
• Sample Sizes Required to Detect Two-Way and Three-Way Interactions Involving Slope Differences in Mixed-Effects Linear Models

  2010cited by this paper
• Alcohol Use Accelerates HIV Disease Progression

  2010cited by this paper
• Alcohol Use and Antiretroviral Adherence: Review and Meta-Analysis

  2009cited by this paper
• Antiretroviral drugs and liver injury.

  2008cited by this paper
• Alcohol use among HIV‐infected persons in care: results of a multi‐site survey *

  2008influential reference
• Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

  2006cited by this paper
• Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

  2006cited by this paper
• Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack of Suppression in HIV Infection

  2006cited by this paper
• Helping Patients Who Drink Too Much

  2005cited by this paper
• A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care.

  2005cited by this paper
• Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir

  2004cited by this paper
• Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism.

  2003influential reference
• The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.

  2002cited by this paper
• Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: Role of hepatitis C and B infections

  2002cited by this paper
• Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

  2002cited by this paper
• The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long‐term retrospective cohort study

  2001cited by this paper
• Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

  2000cited by this paper
• Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

  1998cited by this paper
• Alcohol and mortality in British men: explaining the U-shaped curve.

  1988cited by this paper

• Heavy Alcohol Use and HIV Outcomes: The Moderating Role of Pain

  2024cites this paper
• Impact of alcohol use disorder on antiretroviral therapy adherence in adults with HIV/AIDS at University of Gondar, Northwest Ethiopia

  2024cites this paper
• Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV.

  2022cites this paper
• Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy

  2022cites this paper
• Alcohol Consumption and Risk of Liver Fibrosis in People Living With HIV: A Systematic Review and Meta-Analysis

  2022cites this paper
• Emerging prevalence of fatty liver disease in HIV

  2021cites this paper
• Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment

  2021cites this paper
• Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection

  2021cites this paper
• The longitudinal association between depression, anxiety symptoms and HIV outcomes, and the modifying effect of alcohol dependence among ART clients with hazardous alcohol use in Vietnam

  2021cites this paper
• Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?

  2021cites this paper
• Heavy Alcohol Use is Associated with Lower CD4 Counts among Russian Women Living with HIV: A Multilevel Analysis

  2021cites this paper
• Alcohol-Antiretroviral Therapy Interactive Toxicity Beliefs and Intentional Medication Nonadherence: Review of Research with Implications for Interventions

  2021cites this paper
• Histone deacetylase-2: A potential regulator and therapeutic target in liver disease (Review)

  2021cites this paper
• HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients

  2020cites this paper
• Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: an Updated Review

  2020cites this paper
• Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.

  2019cites this paper
• Alcohol-Related Intentional Antiretroviral Nonadherence among People Living with HIV: Test of an Interactive Toxicity Beliefs Process Model

  2019influential citation
• Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication

  2019cites this paper
• Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco

  2019cites this paper
• Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries

  2018cites this paper
• Gender, Alcohol Use, and Fibrosis in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Individuals.

  2018cites this paper
• Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV

  2018cites this paper
• Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV

  2018cites this paper
• Liver as a target of human immunodeficiency virus infection

  2018cites this paper
• Disrupted ER‐to‐Golgi trafficking underlies anti‐HIV drugs and alcohol‐induced cellular stress and hepatic injury

  2017cites this paper
• Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV.

  2017cites this paper
• Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients.

  2016cites this paper
• Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

  2016cites this paper
• Managing nonalcoholic fatty liver disease in patients living with HIV

  2016cites this paper
• Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection

  2016cites this paper
• Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals

  2015cites this paper